Search Results

You searched for : LatestMercknews  

	Merck Announces U.S. FDA Approval of VAXNEUVANCE for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae, or pneumococcus.... Jul 17
	LYNPARZA (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Treatments in BRCA1/2-Mutated Advanced Prostate Cancer... Jun 24
	Merck to Participate in the Guggenheim Biopharma Strategy Series Merck Research Laboratories, is scheduled to participate in a virtual fireside chat at the Guggenheim Biopharma Strategy Series... Jun 19
	Merck Announces Supply Agreement with U.S. Government for Molnupiravir ... Jun 09
	U.S. FDA Accepts for Priority Review the Biologics License Application for V114 Merck announced the U.S. FDA accepted for priority review a Biologics License Application for V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine, for ... Jan 12
	LYNPARZA (olaparib) Receives Three New Approvals in Japan LYNPARZA has been approved in Japan for the treatment of three types of advanced cancer: ovarian, prostate and pancreatic cancer.... Dec 28
	Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of COVID-19 ... Dec 23
	FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA ... Dec 18
	FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA Patients with newly diagnosed esophageal and GEJ cancer face an aggressive disease with a poor prognosis, despite the currently available treatment options... Dec 17
	KEYTRUDA Plus LENVIMA Combination Demonstrated Statistically Significant Improvement in Overall Survival ... Dec 16
	Merck Receives Positive EU CHMP Opinion for KEYTRUDA as First-Line Treatment for Metastatic Microsatellite Instability ... Dec 11
	Merck Submits Applications for Licensure of V114, the Company’s Investigational 15-valent Pneumococcal Conjugate Vaccine ... Nov 23
	Acquisition adds to Merck’s suite of clinical programs in response to SARS-CoV-2/COVID-19 Meaningful new therapeutic options are desperately needed for possibly millions of people around the world who will develop severe or critical COVID-19 disease... Nov 23
	Merck Advances Phase 3 Trial to Evaluate Investigational Islatravir as Once-Monthly Oral PrEP for Women at High Risk for Acquiring HIV-1 Collaboration with the Bill & Melinda Gates Foundation Seeks to Bring Forward a New HIV Prevention Option with Focus on Women... Nov 16
	KEYTRUDA plus LENVIMA met the trial’s primary endpoint of progression-free survival LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma... Nov 10
	LYNPARZA Approved in the EU for Treatment of BRCA1/2-Mutated Metastatic Castration-Resistant Prostate Cancer Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Agent Treatments in BRCA1/2-Mutated mCRPC... Nov 05
	Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts Merck and the MECTIZAN Donation Program, announced today a $500,000 cash donation to support NGO partners working to eliminate onchocerciasis and lymphatic filariasis... Oct 22
	Merck Announces Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine Pneumococcal disease in adults is on the rise globally, in part driven by disease-causing serotypes not targeted by the currently available pneumococcal conjugate vaccine... Oct 21
	FDA Approves Expanded Indication for Merck’s KEYTRUDA in Adult Patients With classical Hodgkin Lymphoma (cHL) ... Oct 15
	Merck Announces Week 96 Data from Phase 2b Study Evaluating Islatravir With Doravirine for HIV-1 Merck, today announced Week 96 data from the Phase 2b trial evaluating the efficacy and safety of islatravir for HIV-1 infections... Oct 08
	Merck Animal Health Supports Rabies Elimination by 2030 on World Rabies Day Merck Animal Health announced the launch of a global campaign to raise awareness among veterinarians, dog owners and volunteers who are committed to eliminate rabies ... Sep 28
21 Matching result(s) found!

Trending Now
	Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
	Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
	Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
	100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
	Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
	Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
	High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
	Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
	SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
	Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
	Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
	THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
	Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
	Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
	Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
	Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
	Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
	TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
	AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
	Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026